LAMOTRIGINE ER 250 MG TABLET

lamotrigine extended-release
$1.2926per EA

Strength

250 mg/1

NDC

31722024430

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA213949

On Market Since

12/9/2021

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price History

1W

0.0%

1M

+5.0%

3M

+5.9%

6M

+16.3%

1Y

-33.4%

3Y

-66.9%

5Y

N/A

All

-69.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.